Curaleaf Holdings (CURLF) Cash from Operations (2019 - 2024)

Curaleaf Holdings (CURLF) posted quarterly Cash from Operations of 48107000.0 for Q4 2024, up 251.12% year-on-year from 13701000.0 in Q1 2024, and up 13.54% on a QoQ basis from 42370000.0 in Q3 2024.

Curaleaf Holdings (CURLF) Cash from Operations (2019 - 2024) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Cash from Operations for 6 consecutive years, with 48107000.0 the latest figure, recorded in Q4 2024.

  • Quarterly Cash from Operations rose 251.12% year-over-year to 48107000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was 163624000.0 (up 117.41% YoY) and the FY2025 annual result came in at 137706000.0, down 15.84% from the prior year.
  • Cash from Operations advanced to 48107000.0 in Q4 2024 per CURLF's latest filing, from 42370000.0 in the prior quarter.
  • Over the last five years, Cash from Operations for CURLF reached as high as 43776000000.0 in Q1 2024 and fell as low as 43702853000.0 in Q2 2024.
  • A 5-year average of 14463918.75 and a median of 21307500.0 in 2020 frame the typical range for Cash from Operations.
  • Annual changes were most pronounced in 2021 — Cash from Operations surged 180648.47% — and 2023, when it slumped 11641.34%.
  • Year by year, Cash from Operations stood at 19166000.0 in 2020, then tumbled by 260.88% to 30835000.0 in 2021, then soared by 208.38% to 33418000.0 in 2022, then slumped by 59.0% to 13701000.0 in 2023, then soared by 251.12% to 48107000.0 in 2024.
  • According to Business Quant data, Cash from Operations over the past three periods registered 48107000.0, 42370000.0, and 43702853000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -40.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 401.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 1.58 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 463.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 388.30 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 145.80 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 13.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 48.11 Mn
Dec 31, 2024 48.11 Mn
Sep 30, 2024 42.37 Mn
Sep 30, 2024 42.37 Mn
Jun 30, 2024 -43.70 Bn
Jun 30, 2024 -43.70 Bn
Mar 31, 2024 43.78 Bn
Mar 31, 2024 43.78 Bn
Dec 31, 2023 13.70 Mn
Dec 31, 2023 13.70 Mn
Sep 30, 2023 46.82 Mn
Sep 30, 2023 46.82 Mn
Jun 30, 2023 -7.88 Bn
Jun 30, 2023 -7.88 Bn
Mar 31, 2023 7.90 Bn
Mar 31, 2023 7.90 Bn
Dec 31, 2022 33.42 Mn
Dec 31, 2022 33.42 Mn
Sep 30, 2022 43.98 Mn
Sep 30, 2022 43.98 Mn